Since 1993, we have progressively adopted three techniques to reduce transfusion requirements during major orthopedic surgery: red-cell scavenging, acute normovolemic hemodilution, and active patient warming. We retrospectively evaluated all 821 elective hip and knee arthroplasties performed in our institution beginning with July 1993. Target minimal hematocrits were guided by patient ages and cardiovascular status. The first approximately 500-mL blood loss was replaced with crystalloid at a ratio of 3 mL for each milliliter of blood loss. Additional blood loss was replaced with colloid, hemodilution blood (when available), and scavenged red cells (when available). Allogenic transfusions were then administered as necessary to maintain target hematocrits, which were prospectively defined based on the patient ages and cardiovascular health. Univariate analysis was applied initially. Significant predictors of transfusion requirement were subsequently entered into a stepwise multiple regression to account for confounding factors, including age, type of anesthesia (regional versus general) and type of surgery (primary versus hardware replacement). Postoperative hemoglobin concentrations were similar over the years of study and among the patients given each treatment. During the study period, allogenic blood requirements decreased from 1.3 2 1.7 U/patient to 0.6 ? 1.4 U/patient (mean t SD). Both univariate and regression analyses indicated that each treatment significantly reduced transfusion requirements (P < 0.05). We conclude that red-cell scavenging, hemodilution, and active cutaneous warming each reduce allogenic blood requirements during hip and knee arthroplasties. Implications: We retrospectively evaluated three strategies to reduce overall blood loss: red-cell scavenging, acute normovolemic hemodilution, and active patient warming. During the study period, allogenic blood requirements decreased by a factor of 2. Each treatment contributed to this reduction. We therefore conclude that each treatment reduces allogenic blood requirements during hip and knee arthroplasties. (Anesth Analg 1998; 86:387-91 Most patients were given general anesthesia, which was induced by the IV administration of thiopental sodium (3-5 mg/kg), fentanyl (1.5-2.5 pg/kg), and vecuronium (0.10-0.15 mg/kg). The trachea was intubated, and the lungs were ventilated mechanically to maintain the Pace, near 35 mm Hg. Anesthesia was subsequently maintained with nitrous oxide (60%), isoflurane (0.4-0.8% end-tidal concentration), and fentanyl. Isoflurane and fentanyl were administered in doses sufficient to keep the mean arterial blood pressure within 20% of the preinduction values. Spinal anesthesia was used in 36% of the patients; they were given bupivacaine 0.5% (3-5 mL).
During the study period, three methods were used to reduce blood loss or to decrease transfusion requirements.
Red-cell scavenging was introduced first, followed by acute normovolemic hemodilution, and then forced-air cutaneous warming. Because these methods were introduced sequentially, none was used in some patients, whereas two or even three methods were used in others. Additionally, leg tourniquets were used for all knee operations to reduce intraoperative blood loss.
Intra-and postoperative blood loss was scavenged by using a Shiley Stat@ autotransfusion system (Dideco, Inc., Mirandola, Italy). The system was primed with 40,000 IU heparin (Immuno, Inc., Vienna, Austria) in 1000 mL of saline, of which patients received approximately 300 mL. Red blood cells were collected in the scavenger until 600 mL was obtained, and then the cells were centrifuged.
Scavenging from surgical drains was continued for 2 h postoperatively.
A preoperative hematocrit exceeding 34% was required for acute normovolemic hemodilution. Patients were hemodiluted to a hematocrit near 30% by replacing 300-600 mL of blood with an equal volume of colloid plasma expander. Removed blood was stored at room temperature and retransfused at the end of surgery or shortly thereafter. Contraindications to acute normovolemic hemodilution included uncompensated cardiac, pulmonary, or renal disease (7). Patients were actively warmed with forced air by using an upper-body cover. Additionally, IV fluids were warmed in these patients. Measurements recorded for a subset of patients indicated that the mean tympanic membrane temperature in warmed patients was 36.6 5 0.4"C, compared with 35.0 2 0.5"C in unwarmed patients (6). This is consistent with previous studies of active warming (8). The overall strategy for managing allogenic transfusion remained unchanged throughout the study period. An intraoperative target minimal hematocrit was identified based on patient age and cardiovascular status. A target hematocrit of 26% was used in patients aged less than 65 yr who had no significant cardiovascular disease. Significant cardiovascular disease was defined by previous myocardial infarction, angina, congestive heart failure, cardiomyopathy, hypertension, or peripheral vascular disease. A target hematocrit of 28% was used in patients aged mote than 65 yr or those with significant cardiovascular disease. Finally, the hematocrit was maintained at ~30% in patients with cardiovascular disease who were older than 65 yr of age. Postoperatively, sufficient blood was administered to maintain the hematocrit near 28%. This protocol was possible because a strict departmental policy was instituted before the study period. Furthermore, most cases were performed by one anesthesiologist and a single surgical team.
In general, crystalloid was infused throughout surgery at a rate near 10 mL . kg-' * h-l. The first approximately 500-mL estimated blood loss was replaced with additional crystalloid at a ratio of 3 mL for each milliliter of blood loss. Additional blood loss was replaced with colloid, hemodilution blood (when available), and scavenged red cells (when available). Allogenic transfusions were then administered as necessary to maintain the target hematocrit.
The 
Results
We evaluated 821 patients. Among these, 65% underwent primary hip arthroplasties, 27% underwent primary knee arthroplasties, and 8% underwent hip hardware replacement. General anesthesia was used in 64%, and spinal anesthesia was administered to the remaining patients. Red-cell scavenging was used in 578 patients, hemodilution was used in 518 patients, and active warming was used in 532 patients (some patients received more than one treatment). No patients during the first study year were actively warmed, whereas approximately 90% were heated with forced-air during the last study year. The warming status of 142 patients in the middle portion of the study could not be determined from available records. Preoperative hemoglobin concentrations averaged 13.9 -t 1.5 g/dL, and postoperative hemoglobin averaged 10.3 + 1.3 g/dL; neither value changed significantly over the period of study. The requirement for allogenic blood transfusion decreased from 1.3 + 1.7 U in the second half of 1993 to 0.6 5 1.7 U at the end of 1996 (Table 1) . Overall, 528 U of allogenic blood were administered, 85% of which was given postoperatively.
Univariate analyses demonstrated that active warming significantly decreased transfusion requirements, from 0.9 + 1.4 to 0.5 + 1.2 U (P = 0.003). Red-cell scavenging also significantly decreased transfusion requirements, from 0.9 2 1.7 to 0.5 ? 1.2 U (P = 0.0003). Hemodilution markedly decreased transfusion requirements, from 1.1 + 1.9 to 0.4 + 0.9 U (P < 0.0001) ( Table 2) . Transfusion requirements were significantly greater in patients undergoing hip hardware replacement (1.3 t-2.4 U) than in those undergoing primary hip or knee surgery (0.6 + 1.3 U) (P < 0.001). However, transfusion requirements did not differ significantly in patients undergoing primary hip or knee surgery (P = 0.3). Interestingly, the transfusion requirements were similar in patients given general or regional anesthesia (P = 1.0). There was a significant positive relation between the preoperative hemoglobin concentration and the use of hemodilution. Transfusion requirements also decreased significantly over time.
The use of red-cell scavenging, hemodilution, and active warming were entered into a multiple regression, as were patient age, preoperative hemoglobin concentration, and type of surgery. Date of surgery was not entered into the regression because of its co-dependence with active warming. All factors entered into the regression were significant predictors of allogenic transfusion requirement (Table 3) .
Discussion
Numerous strategies have been developed to minimize blood loss and transfusion requirement during major orthopedic surgery. Blood loss nonetheless remains an important problem, and transfusions are often required in patients undergoing these procedure. In the Hospital of Amstetten, allogenic transfusion requirements decreased more than twofold over HGB (g/dL) 13.9 2 1.3 14.3 ? 1.4 14.0 k 1.6 14.0 + 1.3 14.0 + 1.4 13.5 t 1.4 13.7 zk 1.5 13.9 ? 1.5 Scavenging (%)  41  58  67  67  73  77  87  70  Hemodilution  (%)  32  62  71  77  68  59  60 Percentages appl y to each time period. There were no statistically significant differences i n age or i n preoperative and discharge hemoglobin. HGB = hemoglobin. 0.5 2 1.2 0.9 2 1.7* 0.4 2 0.9 1.1 2 1.9* 0.5 + 1.2 0.9 2 1.4* the 3.5-year study period. This decrease was associated with the implementation of three strategies to reduce overall blood loss. Univariate analysis suggested that hemodilution was an important factor in reducing transfusion requirements. Patients receiving hemodilution were half as likely to require transfusion. These data are consistent with previous studies showing that hemodilution decreases blood loss and transfusion requirements (9,lO). As might be expected from the protocol, there was a significant relationship between the preoperative hemoglobin concentration and the use of hemodilution. That is, hemodilution was more likely to have been implemented in patients with higher initial hemoglobin concentrations. These patients were presumably also less likely to require transfusions. Multiple regression analysis, however, indicated that hemodilution had a significant independent effect on transfusion risk. The apparent benefits of hemodilution thus did not result simply from the selection of patients with relatively high initial hemoglobin concentrations.
Both univariate and multiple regression analyses indicated that active warming markedly and significantly reduced the need for allogenic transfusions. These data are consistent with the established effects of hypothermia on platelet function (11-13) and enzymes of the coagulation cascade (14,15). They are also consistent with a recent prospective, randomized trial showing that active warming significantly decreased both blood loss and transfusion requirements (6). As might be expected, reinfusion of scavenged red cells also reduced transfusion requirements. Thus, all three of the strategies that we evaluated reduced the need for allogenic blood.
One advantage of knee surgery is that leg tourniquets can be routinely used to isolate the operative field and reduce blood loss. Intraoperative blood loss is thus usually slight during knee arthroplasties. In contrast, hip arthroplasties are associated with exposed bone surfaces and considerable intraoperative blood loss. Transfusion requirements in the patients undergoing knee and hip procedures were, nonetheless, similar. This observation is consistent with previous data (16) and may be explained by the fact that much of the blood loss associated with these operations occurs postoperatively (6).
A putative benefit of regional anesthesia is reduced blood loss (17). Nonetheless, we did not identify any reduction in transfusion requirements resulting from regional anesthesia. The reason, again, may be that much of the blood loss during orthopedic surgery is postoperative-when the benefits of regional anesthesia have dissipated. That 85% of the units we used were given postoperatively is consistent with this theory, which is why we included the amount of blood administered throughout hospitalization in our analysis.
The major limitation of this study is our retrospective analysis. Consequently, patients were not randomly assigned to specific blood-saving interventions. We therefore cannot independently evaluate timedependent factors such as improvement in surgical technique. However, it seems unlikely that improved surgical technique alone halved transfusion requirements over just 3.5 years. As with any retrospective study, we also cannot eliminate the possibility of bias in assigning treatments. Treatment bias, however, seems unlikely, because blood was administered on the basis of a consistent protocol throughout the study period. Consistent with this protocol, postoperative hemoglobin concentrations were virtually identical in each study period. 1998;86:387-91 SCAVENGING, HEMODILUTION, AND ACTIVE WARMING In summary, allogenic transfusion requirements were similar for primarily knee and hip arthroplasties and for general and regional anesthesia. Most transfusions were given postoperatively.
Transfusion requirements decreased more than twofold over the 3.5-year study period. Our data suggest that red-cell scavenging, hemodilution, and active patient warming all contribute significantly to this reduction.
